Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.64 +0.10 (+1.17%)
At close: Sep 30, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Other financing activities (2026)

Updated

Olema Pharmaceuticals (OLMA) reported Other financing activities of $4.41 million for Q1 2026.

Analysis

Olema Pharmaceuticals (OLMA) Other financing activities (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Olema Pharmaceuticals 755.59 Mn 755.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.41 Mn
API Access

Olema Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=OLMA&period=max&api_key=YOUR_API_KEY